Machine learning and AI research for Patient Benefit: 20 Critical Questions on Transparency, Replicability, Ethics and Effectiveness
Authors:
Sebastian Vollmer,
Bilal A. Mateen,
Gergo Bohner,
Franz J Király,
Rayid Ghani,
Pall Jonsson,
Sarah Cumbers,
Adrian Jonas,
Katherine S. L. McAllister,
Puja Myles,
David Granger,
Mark Birse,
Richard Branson,
Karel GM Moons,
Gary S Collins,
John P. A. Ioannidis,
Chris Holmes,
Harry Hemingway
Abstract:
Machine learning (ML), artificial intelligence (AI) and other modern statistical methods are providing new opportunities to operationalize previously untapped and rapidly growing sources of data for patient benefit. Whilst there is a lot of promising research currently being undertaken, the literature as a whole lacks: transparency; clear reporting to facilitate replicability; exploration for pote…
▽ More
Machine learning (ML), artificial intelligence (AI) and other modern statistical methods are providing new opportunities to operationalize previously untapped and rapidly growing sources of data for patient benefit. Whilst there is a lot of promising research currently being undertaken, the literature as a whole lacks: transparency; clear reporting to facilitate replicability; exploration for potential ethical concerns; and, clear demonstrations of effectiveness. There are many reasons for why these issues exist, but one of the most important that we provide a preliminary solution for here is the current lack of ML/AI- specific best practice guidance. Although there is no consensus on what best practice looks in this field, we believe that interdisciplinary groups pursuing research and impact projects in the ML/AI for health domain would benefit from answering a series of questions based on the important issues that exist when undertaking work of this nature. Here we present 20 questions that span the entire project life cycle, from inception, data analysis, and model evaluation, to implementation, as a means to facilitate project planning and post-hoc (structured) independent evaluation. By beginning to answer these questions in different settings, we can start to understand what constitutes a good answer, and we expect that the resulting discussion will be central to develo** an international consensus framework for transparent, replicable, ethical and effective research in artificial intelligence (AI-TREE) for health.
△ Less
Submitted 21 December, 2018;
originally announced December 2018.
